Efforts to digitalise healthcare for chronic disease patients – including those suffering from diabetes – are helpful, according to the European Public Health Alliance (EPHA). But the move towards digitalisation should not exacerbate existing health inequalities, it warns.
The Maltese EU presidency will seek more transparency in the way pharmaceutical companies negotiate with member states on medicines’ pricing, Health Minister Chris Fearne said in an interview with EURACTIV.
One in seven people with HIV in Europe is unaware of their infection, the EU and World Health Organization reported Tuesday (29 November) as 2015 marked another record year for new HIV cases in the region.
The European Commission is determined to further strengthen its antimicrobial resistance action for the period beyond 2016, an EU official has told EURACTIV.com, dismissing allegations that the EU executive lacks the political will to do so.
The UK's vote to leave the European Union has come at a crucial moment in the development of an international medical project that throws into sharp relief the state of flux Brexit has cast over collaborative research, says Jack Barton.
A new breed of drugs, called “value added medicines”, could help patients improve their everyday life while in treatment, without increasing healthcare budgets, Christoph Stoller said in an interview with EURACTIV.com